“Our top picks are large-caps Astro, Axiata, Dialog, GENM, Tenaga and mid-caps BAT, Duopharma, Globetronics, Magnum and Scientex," UOB Kay Hian Malaysia Research said in its strategy report.
KUALA LUMPUR: UOB Kay Hian Malaysia Research is maintaining its end-2020 FBM KLCI target of 1,440 as it will need to reassess the pace of the post-movement control order (MCO) recovery of economic activities.
With the latest earnings cut, the research house’s target implies target PE multiples of 16.4 times 2020F and 14.8 times 2021F, and target price-to-book (P/B) of 1.26 times (-2.6 standard deviation to mean).
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
